Source: MarketScreener

Goetz Partners: Immutep : Goetzpartners securities - Fully exploiting LAG3 oncology game changer. Reit Buy, A$2.88 tgt (Dr Chris Redhead)

(marketscreener.com) IMMUTEP LIMITED Biotechnology 13 September 2023 11:55 BST COMPANY NOTE Immutep Limited Fully exploiting LAG3 oncology game changer ...https://www.marketscreener.com/quote/stock/IMMUTEP-LIMITED-38892320/news/Immutep-Goetzpartners-securities-Fully-exploiting-LAG3-oncology-game-changer-Reit-Buy-A-2-88-t-44833957/?utm_medium=RSS&utm_content=20230913

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
250-500
Stephan Goetz's photo - Managing Partner of Goetz Partners

Managing Partner

Stephan Goetz

CEO Approval Rating

90/100

Read more